Methylglyoxal (MGO), a cytotoxic metabolite of glycolysis, can cause endothelial cells impairment, which is tightly associated with diabetic vascular complication. Umbelliferone, a derivative of coumarin, participates in various pharmacological activities. This study aimed to determine the effectiveness of umbelliferone in MGO‐induced apoptosis and oxidative stress in endothelial cells. In this study, it has been indicated that umbelliferone inhibited MGO‐induced human umbilical vein endothelial cells (HUVECs) cytotoxicity, apoptosis, Bax/Bcl‐2 protein ratio, the activity of cleaved‐caspase‐3, and mitochondrial membrane potential loss. Furthermore, we found that umbelliferone inhibited MGO‐induced activation of mitogen‐activated protein kinases and nuclear factor‐κB signaling pathways in HUVECs. In addition, umbelliferone could suppress oxidative stress, as evidenced by decrease of reactive oxygen species and malondialdehyde (MDA) generation, and increase of superoxide dismutase and glutathione peroxidase contents. Moreover, we found that umbelliferone can activate Nrf2/HO‐1 signaling. Importantly, silencing of Nrf2 signaling clearly eliminated the anti‐oxidative stress of umbelliferone, whereas umbelliferone pretreatment had no effect on Nrf2 overexpressing HUVECs. Altogether, this study suggested that umbelliferone pretreatment has a protective effect on MGO‐induced endothelial cell dysfunction through inhibiting apoptosis and oxidative stress.